Liberate Bio
- Biotech or pharma, therapeutic R&D
Liberate is a Khosla Ventures backed biotech advancing an in-vivo CAR-M program for solid tumors and in-vivo sickle cell efforts (NHP studies), as well as its RAPTOR technology for extrahepatic, non-viral delivery of genetic and cancer medicines.